Glynis L. Kolling
Research Associate Professor of Biomedical Engineering, Biomedical Engineering
Bio & Overview
Academic Information
- Department
- Biomedical Engineering
Primary Education
- BS, Food Science, Ohio State University, 1996
- PhD, Food Science, Rutgers University, 2003
Other Appointments
- Postdoctoral Researcher, Medicine- Nephrology
Other Affiliations
- BIMS
Research Interests
Selected Publications
2022
Ledwaba, S. E., Bolick, D. T., Quintela Soares de Medeiros, P. H., Kolling, G. L., Traore, A. N., Potgieter, N., . . . Guerrant, R. L. (2022). Enteropathogenic Escherichia coli (EPEC) expressing a non-functional bundle-forming pili (BFP) also leads to increased growth failure and intestinal inflammation in C57BL/6 mice. BRAZILIAN JOURNAL OF MICROBIOLOGY, 53(4), 1781-1787. doi:10.1007/s42770-022-00802-5
2021
Dunphy, L. J., Kolling, G. L., Jenior, M. L., Carroll, J., Attai, A. E., Farnoud, F., . . . Papin, J. A. (2021). Multidimensional Clinical Surveillance of Pseudomonas aeruginosa Reveals Complex Relationships between Isolate Source, Morphology, and Antimicrobial Resistance. MSPHERE, 6(4). doi:10.1128/mSphere.00393-21
Dunphy, L. J., Grimes, K. L., Wase, N., Kolling, G. L., & Papin, J. A. (2021). Untargeted Metabolomics Reveals Species-Specific Metabolite Production and Shared Nutrient Consumption by Pseudomonas aeruginosa and Staphylococcus aureus. MSYSTEMS, 6(3). doi:10.1128/mSystems.00480-21
Dougherty, B. V., Rawls, K. D., Kolling, G. L., Vinnakota, K. C., Wallqvist, A., & Papin, J. A. (2021). Identifying functional metabolic shifts in heart failure with the integration of omics data and a heart-specific, genome-scale model. CELL REPORTS, 34(10). doi:10.1016/j.celrep.2021.108836
Grimes, K. L., Dunphy, L. J., Kolling, G. L., Papin, J. A., & Colosi, L. M. (2021). Algae-mediated treatment offers apparent removal of a model antibiotic resistance gene. ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 60. doi:10.1016/j.algal.2021.102540
Costa, D. V. S., Moura-Neto, V., Bolick, D. T., Guerrant, R. L., Fawad, J. A., Shin, J. H., . . . Brito, G. A. C. (2021). S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Clostridioides difficile Infection by Modulating Inflammatory Response. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 11. doi:10.3389/fcimb.2021.739874
2020
Rawls, K. D., Dougherty, B. V., Vinnakota, K. C., Pannala, V. R., Wallqvist, A., Kolling, G. L., & Papin, J. A. (2021). Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. TOXICOLOGY AND APPLIED PHARMACOLOGY, 412. doi:10.1016/j.taap.2020.115390
Moore, J. H., Honrado, C., Stagnaro, V., Kolling, G., Warren, C. A., & Swami, N. S. (2020). Rapid in Vitro Assessment of Clostridioides difficile Inhibition by Probiotics Using Dielectrophoresis to Quantify Cell Structure Alterations. ACS INFECTIOUS DISEASES, 6(5), 1000-1007. doi:10.1021/acsinfecdis.9b00415
Medeiros, P. H. Q. S., Bolick, D. T., Ledwaba, S. E., Kolling, G. L., Costa, D. V. S., Oriá, R. B., . . . Guerrant, R. L. (2020). A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice.. NPJ vaccines, 5(1), 30. doi:10.1038/s41541-020-0180-y
Liu, Y., Moore, J. H., Kolling, G. L., McGrath, J. S., Papin, J. A., & Swami, N. S. (2020). Minimum bactericidal concentration of ciprofloxacin to Pseudomonas aeruginosa determined rapidly based on pyocyanin secretion. SENSORS AND ACTUATORS B-CHEMICAL, 312. doi:10.1016/j.snb.2020.127936
Medeiros, P. H. Q. S., Bolick, D. T., Ledwaba, S. E., Kolling, G. L., Costa, D. V. S., Oria, R. B., . . . Guerrant, R. L. (2020). A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice. NPJ VACCINES, 5(1). doi:10.1038/s41541-020-0180-y
2019
Rawls, K. D., Blais, E. M., Dougherty, B. V., Vinnakota, K. C., Pannala, V. R., Wallqvist, A., . . . Papin, J. A. (2019). Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes. TOXICOLOGICAL SCIENCES, 172(2), 279-291. doi:10.1093/toxsci/kfz197
Grimes, K. L., Dunphy, L. J., Loudermilk, E. M., Melara, A. J., Kolling, G. L., Papin, J. A., & Colosi, L. M. (2019). Evaluating the efficacy of an algae-based treatment to mitigate elicitation of antibiotic resistance. CHEMOSPHERE, 237. doi:10.1016/j.chemosphere.2019.124421
Shin, J. H., Chaplin, A. S., Hays, R. A., Kolling, G. L., Vance, S., Guerrant, R. L., . . . Warren, C. A. (2019). Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis. JOURNAL OF CLINICAL MEDICINE, 8(7). doi:10.3390/jcm8071036
Liu, Y., McGrath, J. S., Moore, J. H., Kolling, G. L., Papin, J. A., & Swami, N. S. (2019). Electrofabricated biomaterial-based capacitor on nanoporous gold for enhanced redox amplification. ELECTROCHIMICA ACTA, 318, 828-836. doi:10.1016/j.electacta.2019.06.127
2018
Rawls, K. D., Dougherty, B. V., Blais, E. M., Stancliffe, E., Kolling, G. L., Vinnakota, K., . . . Papin, J. A. (2019). A simplified metabolic network reconstruction to promote understanding and development of flux balance analysis tools. COMPUTERS IN BIOLOGY AND MEDICINE, 105, 64-71. doi:10.1016/j.compbiomed.2018.12.010
Bartelt, L. A., Bolick, D. T., Kolling, G. L., Stebbins, E., Huston, C. D., Guerrant, R. L., & Hoffman, P. S. (2018). Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have In Vitro Activity against Cryptosporidium. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(12). doi:10.1128/AAC.00718-18
Medlock, G. L., Carey, M. A., McDuffie, D. G., Mundy, M. B., Giallourou, N., Swann, J. R., . . . Papin, J. A. (2018). Inferring Metabolic Mechanisms of Interaction within a Defined Gut Microbiota. CELL SYSTEMS, 7(3), 245-+. doi:10.1016/j.cels.2018.08.003
Giallourou, N., Medlock, G. L., Bolick, D. T., Medeiros, P. H. Q. S., Ledwaba, S. E., Kolling, G. L., . . . Guerrant, R. L. (2018). A novel mouse model of Campylobacter jejuni enteropathy and diarrhea. PLOS PATHOGENS, 14(5). doi:10.1371/journal.ppat.1007083
Medlock, G., Carey, M., McDuffie, D., Mundy, M., Giallourou, N., Swann, J., . . . Papin, J. (2018). Metabolic mechanisms of interaction within a defined gut microbiota. doi:10.1101/250860
Borgersen, Q., Bolick, D. T., Kolling, G. L., Aijuka, M., Ruiz-Perez, F., Guerrant, R. L., . . . Santiago, A. E. (2018). Abundant production of exopolysaccharide by EAEC strains enhances the formation of bacterial biofilms in contaminated sprouts. GUT MICROBES, 9(3), 264-278. doi:10.1080/19490976.2018.1429877
2017
Shin, J. H., Gao, Y., Moore, J. H. I. I., Bolick, D. T., Kolling, G. L., Wu, M., & Warren, C. A. (2018). Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host. JOURNAL OF INFECTIOUS DISEASES, 217(2), 188-197. doi:10.1093/infdis/jix414
Bartelt, L. A., Bolick, D. T., Mayneris-Perxachs, J., Kolling, G. L., Medlock, G. L., Zaenker, E. I., . . . Guerrant, R. L. (2017). Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with Giardia lamblia and enteroaggregative Escherichia coli. PLOS PATHOGENS, 13(7). doi:10.1371/journal.ppat.1006471
Bolick, D. T., Mayneris-Perxachs, J., Medlock, G. L., Kolling, G. L., Papin, J. A., Swann, J. R., & Guerrant, R. L. (2017). Increased Urinary Trimethylamine N-Oxide Following Cryptosporidium Infection and Protein Malnutrition Independent of Microbiome Effects. JOURNAL OF INFECTIOUS DISEASES, 216(1), 64-71. doi:10.1093/infdis/jix234
Blais, E. M., Rawls, K. D., Dougherty, B. V., Li, Z. I., Kolling, G. L., Ye, P., . . . Papin, J. A. (2017). Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. NATURE COMMUNICATIONS, 8. doi:10.1038/ncomms14250
Moutinho, T., Panagides, J., Biggs, M., Medlock, G., Kolling, G., & Papin, J. (2017). Novel co-culture plate enables growth dynamic-based assessment of contact-independent microbial interactions. doi:10.1101/145615
Moutinho, T. J. J., Panagides, J. C., Biggs, M. B., Medlock, G. L., Kolling, G. L., & Papin, J. A. (2017). Novel co-culture plate enables growth dynamic-based assessment of contact-independent microbial interactions. PLOS ONE, 12(8). doi:10.1371/journal.pone.0182163
2016
Liu, J., Bolick, D. T., Kolling, G. L., Fu, Z., & Guerrant, R. L. (2016). Protein Malnutrition Impairs Intestinal Epithelial Cell Turnover, a Potential Mechanism of Increased Cryptosporidiosis in a Murine Model. INFECTION AND IMMUNITY, 84(12), 3542-3549. doi:10.1128/IAI.00705-16
Biggs, M. B., Medlock, G. L., Moutinho, T. J., Lees, H. J., Swann, J. R., Kolling, G. L., & Papin, J. A. (2017). Systems-level metabolism of the altered Schaedler flora, a complete gut microbiota. ISME JOURNAL, 11(2), 426-438. doi:10.1038/ismej.2016.130
Mayneris-Perxachs, J., Bolick, D. T., Leng, J., Medlock, G. L., Kolling, G. L., Papin, J. A., . . . Guerrant, R. L. (2016). Protein- and zinc-deficient diets modulate the murine microbiome and metabolic phenotype. AMERICAN JOURNAL OF CLINICAL NUTRITION, 104(5), 1253-1262. doi:10.3945/ajcn.116.131797
Bartelt, L. A., Bolick, D. T., Kolling, G. L., Roche, J. K., Zaenker, E. I., Lara, A. M., . . . Guerrant, R. L. (2016). Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model. PLOS NEGLECTED TROPICAL DISEASES, 10(7). doi:10.1371/journal.pntd.0004820
Oria, R. B., Murray-Kolb, L. E., Scharf, R. J., Pendergast, L. L., Lang, D. R., Kolling, G. L., & Guerrant, R. L. (2016). Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children. NUTRITION REVIEWS, 74(6), 374-386. doi:10.1093/nutrit/nuw008
van Opstal, E., Kolling, G. L., Mooreii, J. H., Coquery, C. M., Wade, N. S., Loo, W. M., . . . Warren, C. A. (2016). Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection. JOURNAL OF INFECTIOUS DISEASES, 214(1), 130-139. doi:10.1093/infdis/jiw071
Moore, J. H. I. I., van Opstal, E., Kolling, G. L., Shin, J. H., Bogatcheva, E., Nikonenko, B., . . . Warren, C. A. (2016). Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(5), 1300-1306. doi:10.1093/jac/dkv479
2015
Moore, J. H., Pinheiro, C. C. D., Zaenker, E. I., Bolick, D. T., Kolling, G. L., van Opstal, E., . . . Warren, C. A. (2015). Correction: Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.. PloS one, 10(9), e0137037. doi:10.1371/journal.pone.0137037
Moore, J. H., Pinheiro, C. C. D., Zaenker, E. I., Bolick, D. T., Kolling, G. L., van Opstal, E., . . . Warren, C. A. (2015). Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model. PLOS ONE, 10(7). doi:10.1371/journal.pone.0131829
Biggs, M. B., Medlock, G. L., Kolling, G. L., & Papin, J. A. (2015). Metabolic network modeling of microbial communities. WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 7(5), 317-334. doi:10.1002/wsbm.1308
Obata, F., Subrahmanyam, P. B., Vozenilek, A. E., Hippler, L. M., Jeffers, T., Tongsuk, M., . . . Webb, T. J. (2015). Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice. FRONTIERS IN MICROBIOLOGY, 6. doi:10.3389/fmicb.2015.00262
2014
Bolick, D. T., Koring, G. L., Moore, J. H. I. I., de Oliveira, L. A., Tung, K., Philipson, C., . . . Guerrant, R. L. (2014). Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative escherichia coli-induced diarrhea. GUT MICROBES, 5(5), 618-627. doi:10.4161/19490976.2014.969642
2013
Madan, R., Guo, X., Naylor, C., Buonomo, E. L., Mackay, D., Noor, Z., . . . Petri, W. A. J. (2014). Role of Leptin-Mediated Colonic Inflammation in Defense against Clostridium difficile Colitis. INFECTION AND IMMUNITY, 82(1), 341-349. doi:10.1128/IAI.00972-13
Amran, M. Y., Fujii, J., Kolling, G. L., Villanueva, S. Y. A. M., Kainuma, M., Kobayashi, H., . . . Yoshida, S. -I. (2013). Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice. MICROBIAL PATHOGENESIS, 65, 57-62. doi:10.1016/j.micpath.2013.09.008
Medeiros, P., Bolick, D. T., Roche, J. K., Noronha, F., Pinheiro, C., Kolling, G. L., . . . Guerrant, R. L. (2013). The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host. VIRULENCE, 4(7), 624-633. doi:10.4161/viru.26120
D'Auria, K. M., Kolling, G. L., Donato, G. M., Warren, C. A., Gray, M. C., Hewlett, E. L., & Papin, J. A. (2013). In Vivo Physiological and Transcriptional Profiling Reveals Host Responses to Clostridium difficile Toxin A and Toxin B. INFECTION AND IMMUNITY, 81(10), 3814-3824. doi:10.1128/IAI.00869-13
Bartelt, L. A., Roche, J., Kolling, G., Bolick, D., Noronha, F., Naylor, C., . . . Guerrant, R. (2013). Persistent G. lamblia impairs growth in a murine malnutrition model. JOURNAL OF CLINICAL INVESTIGATION, 123(6), 2672-2684. doi:10.1172/JCI67294
Rodrigues, R. S., Oliveira, R. A. C., Li, Y., Zaja-Milatovic, S., Costa, L. B., Braga Neto, M. B., . . . Warren, C. A. (2013). Intestinal Epithelial Restitution After TcdB Challenge and Recovery From Clostridium difficile Infection in Mice With Alanyl-Glutamine Treatment. JOURNAL OF INFECTIOUS DISEASES, 207(10), 1505-1515. doi:10.1093/infdis/jit041
Kolling, G. L., Wu, M., Warren, C. A., Durmaz, E., Klaenhammer, T. R., Timko, M. P., & Guerrant, R. L. (2013). Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production (vol 3, pg 523, 2012). GUT MICROBES, 4(2), 175. doi:10.4161/gmic.24005
Amran, M. Y., Fujii, J., Suzuki, S. O., Kolling, G. L., Villanueva, S. Y. A. M., Kainuma, M., . . . Yoshida, S. -I. (2013). Investigation of Encephalopathy Caused by Shiga Toxin 2c-Producing Escherichia coli Infection in Mice. PLOS ONE, 8(3). doi:10.1371/journal.pone.0058959
2012
Li, Y., Figler, R. A., Kolling, G., Bracken, T. C., Rieger, J., Stevenson, R. W., . . . Warren, C. A. (2012). Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment. BMC INFECTIOUS DISEASES, 12. doi:10.1186/1471-2334-12-342
Warren, C. A., van Opstal, E. J., Riggins, M. S., Li, Y., Moore, J. H., Kolling, G. L., . . . Hoffman, P. S. (2013). Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 57(2), 689-696. doi:10.1128/AAC.00877-12
Warren, C. A., van Opstal, E., Ballard, T. E., Kennedy, A., Wang, X., Riggins, M., . . . Hoffman, P. S. (2012). Amixicile, a Novel Inhibitor of Pyruvate:Ferredoxin Oxidoreductase, Shows Efficacy against Clostridium difficile in a Mouse Infection Model. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 56(8), 4103-4111. doi:10.1128/AAC.00360-12
D'Auria, K. M., Donato, G. M., Gray, M. C., Kolling, G. L., Warren, C. A., Cave, L. M., . . . Hewlett, E. L. (2012). Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control. BMC SYSTEMS BIOLOGY, 6. doi:10.1186/1752-0509-6-2
Stone, S. M., Thorpe, C. M., Ahluwalia, A., Rogers, A. B., Obata, F., Vozenilek, A., . . . Jandhyala, D. M. (2012). Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2. doi:10.3389/fcimb.2012.00135
Kolling, G. L., Wu, M., Warren, C. A., Durmaz, E., Klaenhammer, T. R., Timko, M. P., & Guerrant, R. L. (2012). Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production. GUT MICROBES, 3(6), 523-529. doi:10.4161/gmic.21757
Kolling, G., Wu, M., & Guerrant, R. L. (2012). Enteric pathogens through life stages. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2. doi:10.3389/fcimb.2012.00114
2011
Pawlowski, S. W., Calabrese, G., Kolling, G. L., Platts-Mills, J., Freire, R., Warren, C. A., . . . Guerrant, R. L. (2011). Murine model of Clostridium difficile infection (CDI) using aged gnotobiotic C57BL/6 mice and a BI strain (vol 202, pg 1708, 2010). JOURNAL OF INFECTIOUS DISEASES, 203(10), 1505. doi:10.1093/infdis/jir055
2010
Pawlowski, S. W., Calabrese, G., Kolling, G. L., Freire, R., AlcantaraWarren, C., Liu, B., . . . Guerrant, R. L. (2010). Murine Model of Clostridium difficile Infection with Aged Gnotobiotic C57BL/6 Mice and a BI/NAP1 Strain. JOURNAL OF INFECTIOUS DISEASES, 202(11), 1708-1712. doi:10.1086/657086
Rodrigues, R. S., Neto, J. L., Lima, A. A., Warren, C. A., Kolling, G., & Guerrant, R. L. (2010). EFFECTS OF ALANYL-GLUTAMINE IN IEC-6 CELLS CHALLENGED WITH CLOSTRIDIUM DIFFICILE TOXINS. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 83(5), 192. Retrieved from https://www.webofscience.com/